EHE 360 Connect

Prepare for Progress: Genomic Profiling to Inform Treatment Development and Care Planning

By Maggie Cameron / October 23, 2025 / Comments Off on Prepare for Progress: Genomic Profiling to Inform Treatment Development and Care Planning

Prepare for Progress: Genomic Profiling to Inform Treatment Development and Care Planning Thursday, December 4, 2025 12:00 – 1:00 pm ET Join the EHE Foundation for a conversation about genomic profiling — an important tool that can help guide treatment decisions, support and inform clinical trials, and pave a path to progress in EHE research.  Dr. […]

Read More

Exploring Histotripsy as a Treatment Option for EHE

By Maggie Cameron / September 8, 2025 / Comments Off on Exploring Histotripsy as a Treatment Option for EHE

Exploring Histotripsy as a Treatment Option for EHE Tuesday, October 14, 2025 4:00 – 5:00 pm ET Dr. Jiping Wang, Surgical Oncologist, Dana-Farber Cancer Institute Dr. Paul Shyn, Department of Radiology, Brigham and Women’s Hospital Dr. Michael Wagner, Medical Oncologist, Dana-Farber Cancer Institute Join us for an educational discussion on histotripsy, an emerging treatment for […]

Read More

Understanding Palliative Care: An Extra Layer of Support in Your Care Journey

By Maggie Cameron / July 10, 2025 / Comments Off on Understanding Palliative Care: An Extra Layer of Support in Your Care Journey

Understanding Palliative Care: An Extra Layer of Support in Your Care Journey Tuesday, September 23, 2025 6:00 – 7:00 pm ET Elizabeth Loggers, MD, PhD Medical Director, Supportive and Palliative Care Fred Hutchinson Cancer Center Join us for an enlightening webinar with Dr. Elizabeth Loggers, Medical Director of Supportive and Palliative Care at the Fred […]

Read More
Results of a Phase 2 Trial of Trametinib in Advanced EHE

EHE 360 Connect – Results of Phase 2 Trial of Trametinib in EHE

By Maggie Cameron / January 11, 2025 / Comments Off on EHE 360 Connect – Results of Phase 2 Trial of Trametinib in EHE

Dr. Scott M. Schuetze, University of Michigan, Rogel Cancer Center, will provide an overview of the rationale for treatment of EHE with trametinib, an oral inhibitor of the MEK kinase; the trial design of 10015/SARC033; and the results of the primary and secondary study endpoints. The presentation will also include an update on exploratory investigation […]

Read More
EHE 360 Connect: Sirolimus for the Treatment of EHE

EHE 360 Connect: Sirolimus for the Treatment of EHE

By Maggie Cameron / January 7, 2025 / Comments Off on EHE 360 Connect: Sirolimus for the Treatment of EHE

Join us for EHE 360 Connect on Wednesday, January 22, 2025, 12:00-1:00 pm ET. This webinar features Dr. Silvia Stacchiotti, Medical Oncologist at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, presenting “Sirolimus for the Treatment of EHE.” In this session, Dr. Stacchiotti will highlight data currently available on the use of Sirolimus to […]

Read More
EHE 360 Connect: The Lamar Lab - Harnessing the Therapeutic Power of the Hippo Pathway in EHE

EHE 360 Connect: The Lamar Lab – Harnessing the Therapeutic Potential of the Hippo Pathway in EHE

By Maggie Cameron / July 30, 2024 / Comments Off on EHE 360 Connect: The Lamar Lab – Harnessing the Therapeutic Potential of the Hippo Pathway in EHE
Read More